National Centre for Immunisation Research & Surveillance

Recent papers from National Centre for Immunisation Research & Surveillance

1. Impact of single-dose universal varicella vaccination program on paediatric varicella-zoster virus-related hospitalisations in Australia, 2002–2022Vaccine · 2026
2. Exploring the Links Between NITAGs and Academic Institutions: A Landscape AnalysisVaccines · 2026
3. Short‐Term Adverse Events Following Recombinant Zoster Vaccination in Older Adults in Australia: A Survey Study Comparing Dose 1 and Dose 2 and Influence of Dose IntervalThe Medical Journal of Australia · 2026
4. Nirsevimab provides age-specific protection against RSV hospitalisation in the first year of life: a population-level study in Queensland, AustraliaCommunicable Diseases Intelligence · 2026
5. Envolvimento público no Registro Brasileiro de Paralisia Cerebral: um estudo exploratório, sequencial, de métodos mistosDevelopmental Medicine & Child Neurology · 2026
6. Seroprevalence of 17 pathogens from an integrated national serosurvey in NiueScientific Reports · 2026
7. Anesthesia as a Partner in Public Health: Enabling National Pediatric SARS-CoV-2 Serosurveillance in AustraliaAnesthesiology · 2026
8. Public involvement in the Brazilian Cerebral Palsy Register: An exploratory, sequential, mixed‐methods studyDevelopmental Medicine & Child Neurology · 2026
9. Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2019–2022Communicable Diseases Intelligence · 2026
10. Surveillance for severe influenza, COVID-19, and RSV in patients admitted to sentinel Australian hospitals in 2025: the Influenza Complications Alert Network (FluCAN) and the Paediatric Active Enhanced Disease Surveillance (PAEDS) systemCommunicable Diseases Intelligence · 2026
11. Sero-catalytic and spatial modeling of dengue virus force of infection in Timor-LesteNature Communications · 2026
12. Short‐Term Safety of Concomitant Meningococcal B and National Immunisation Program Vaccines in Infants Aged < 15 Months: A Survey‐Based Surveillance StudyThe Medical Journal of Australia · 2026
13. “I know how important it is”: A qualitative analysis of participants’ experiences in a vaccine safety studyHuman Vaccines & Immunotherapeutics · 2026
14. COVID-19 disruption and rebound of respiratory syncytial virus hospital burden in Australia: A national interrupted time-series analysisJournal of Infection and Public Health · 2026
15. Long-term outcomes of childhood encephalitis in Australia: burden and predictors from the Australian childhood encephalitis (ACE) prospective multicentre cohortThe Lancet Regional Health - Western Pacific · 2026
16. Estimating current susceptibility to measles in Australia following sustained measles eliminationAustralian and New Zealand Journal of Public Health · 2026
17. Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN NetworkThe Lancet Regional Health - Western Pacific · 2026
18. Sexually transmitted infection prevalence following azithromycin mass drug administration for trachoma in Nauru: a before-and-after cross-sectional surveySexually Transmitted Infections · 2026
19. Changing COVID-19 vaccine effectiveness against COVID-19 mortality in older adults in Australia, 2022-2025Communications Health · 2026
20. A Multidesign Study of 4CMenB Vaccine Effectiveness and Impact on Meningococcal Carriage and Gonorrhea in Northern Territory Adolescents and Young PeopleOpen Forum Infectious Diseases · 2026